Continuation and Expansion of the National Mesothelioma Virtual Bank for Translational Research (U24)
ID: 360194Type: Posted
Overview

Buyer

Centers for Disease Control and Prevention - ERA (HHS-CDC-HHSCDCERA)

Award Range

$1M - $1M

Eligible Applicants

Unrestricted

Funding Category

Health

Funding Instrument

Cooperative Agreement

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes
Timeline
    Description

    The Centers for Disease Control and Prevention (CDC) is offering a funding opportunity for the continuation and expansion of the National Mesothelioma Virtual Bank for Translational Research (U24). This cooperative agreement aims to enhance the collection of biospecimens and related data to support biomedical research on malignant mesothelioma, requiring applicants to have an established registry and tissue bank capable of functioning as a national resource. The initiative is crucial for advancing research into early disease markers, treatment modalities, and improving health outcomes for mesothelioma patients. The total estimated funding for this program is $5.5 million, with a ceiling and floor award amount of $1.1 million, and applications must be submitted electronically by March 23, 2026, with an anticipated award date of August 1, 2026. For further inquiries, interested parties can contact Bridgette Garrett at bgarrett@cdc.gov or by phone at 770-488-5715.

    Point(s) of Contact
    Files
    No associated files provided.
    Similar Opportunities
    Extension of the World Trade Center Health Registry (U50)
    Centers for Disease Control and Prevention - ERA
    The Centers for Disease Control and Prevention (CDC) is offering a cooperative agreement to extend the World Trade Center (WTC) Health Registry, with an estimated total program funding of $44 million over five years. The primary objective is to solicit research applications that will enhance the Registry, which monitors the health of individuals exposed to the 9/11 disaster, ensuring ongoing data collection and assessment of long-term health effects. This initiative is crucial for public health as it provides a centralized database for understanding the impacts of the 9/11 attacks and informs healthcare policy and disaster response planning. Interested applicants, which may include government entities, non-profits, and private institutions (excluding foreign entities), must submit their applications by February 20, 2026, with an optional letter of intent due by January 22, 2026. For further inquiries, contact Eduardo O'Neill, PhD, at fzt4@cdc.gov.
    Exploratory/Developmental Grants Related to the World Trade Center Health Program (R21)
    Centers for Disease Control and Prevention - ERA
    The Centers for Disease Control and Prevention (CDC) is offering exploratory and developmental grants related to the World Trade Center Health Program (R21) to support research addressing diagnostic and treatment uncertainties for individuals affected by the 9/11 attacks. This funding opportunity aims to encourage innovative research projects that explore new areas of investigation, potentially leading to significant advancements in treatment effectiveness and diagnostic practices for those receiving monitoring and treatment under the James Zadroga 9/11 Health and Compensation Act. With an estimated total program funding of $30 million and an expected 60 awards, applicants can request funding ranging from $0 to $365,000. Interested parties should note that applications are due by 5:00 PM local time on February 12, 2026, and can direct inquiries to Dr. Eduardo O'Neill at 404-718-8844 or via email at fzt4@cdc.gov.
    Cooperative Research Agreements Related to the World Trade Center Health Program (U01)
    Centers for Disease Control and Prevention - ERA
    The Centers for Disease Control and Prevention (CDC) is forecasting a funding opportunity for Cooperative Research Agreements related to the World Trade Center (WTC) Health Program, aimed at addressing health conditions stemming from the September 11, 2001, terrorist attacks. This initiative seeks scientifically rigorous research proposals that focus on improving diagnosis and treatment, expanding knowledge about health effects, and enhancing response strategies for future disasters, particularly for WTC responders and survivors. With an estimated total program funding of $41.25 million and an award ceiling of $550,000, the CDC anticipates making approximately 25 awards. Interested applicants can reach out to Dr. James Yiin at JYiin@cdc.gov or call 513-841-4271 for further information, with applications due by October 28, 2025, and awards expected to be announced by June 26, 2026.
    Assessment and Evaluation of Emerging Health Conditions Relevant to the World Trade Center Health Program (U01)
    Centers for Disease Control and Prevention - ERA
    The Centers for Disease Control and Prevention (CDC) is forecasting a federal grant opportunity titled "Assessment and Evaluation of Emerging Health Conditions Relevant to the World Trade Center Health Program (U01)." This cooperative agreement aims to support research projects that investigate health conditions potentially related to the September 11, 2001, terrorist attacks, focusing on diagnosing and treating conditions that have emerged since the establishment of the WTC Health Program. The initiative is particularly interested in interdisciplinary collaborations that address health equity and the health burdens faced by vulnerable populations exposed to the 9/11 attacks. The estimated total program funding is $33 million, with an award ceiling of $550,000 and approximately 20 awards expected. Interested applicants can reach out to Dr. James Yiin at JYiin@cdc.gov or by phone at 513-841-4271, with applications due by October 28, 2025, and awards anticipated by June 26, 2026.
    Preparedness for and Prevention of Severe Disease and Sequelae of Respiratory Viruses and Other Respiratory Pathogens
    Centers for Disease Control and Prevention - ERA
    The Centers for Disease Control and Prevention (CDC) is offering a funding opportunity titled "Preparedness for and Prevention of Severe Disease and Sequelae of Respiratory Viruses and Other Respiratory Pathogens" through a cooperative agreement. This initiative aims to support research focused on preventing and mitigating severe respiratory illnesses and their complications by investigating the epidemiology, prevention, treatment, and outcomes associated with respiratory viruses and other pathogens. The program is crucial for enhancing public health infrastructure and clinical outcomes related to respiratory diseases, particularly for high-risk populations such as pregnant women, infants, and older adults. The total estimated funding for this program is $50 million, with individual awards ranging from $1.5 million to $2 million, and applications are due by March 1, 2026. Interested applicants can reach out to Amy Yang at AYang@cdc.gov or call 404-718-8836 for further information.
    Building National Partnerships for the Prevention of Emerging and Reemerging Infectious Diseases
    Centers for Disease Control - NCEZID
    The Centers for Disease Control and Prevention (CDC) is offering a cooperative agreement titled "Building National Partnerships for the Prevention of Emerging and Reemerging Infectious Diseases." This initiative aims to enhance the nation's capacity to prevent, detect, and respond to infectious disease threats by supporting healthcare professionals, systems, and organizations involved in public health and patient care. The program emphasizes strengthening critical infrastructure, workforce training, and emergency response capabilities, particularly focusing on antimicrobial resistance and infection control. With an estimated total funding of $150 million, the CDC anticipates awarding approximately 15 grants, with individual awards ranging from $1 million to $30 million. Interested applicants can contact Trisia Shannon at 404-639-0063 or via email at xki5@cdc.gov, with applications due by April 18, 2026, and project start dates expected by September 30, 2026.
    Promoting World Trade Center Health Program Youth Research Cohort Recruitment and Retention Using Principles of Community Engaged Research (CEnR) to Build Community Participation (U01)
    Centers for Disease Control and Prevention - ERA
    The Centers for Disease Control and Prevention (CDC) is inviting applications for the Promoting World Trade Center Health Program Youth Research Cohort Recruitment and Retention project, aimed at enhancing community engagement through Community Engaged Research (CEnR) principles. The initiative seeks to establish authentic partnerships between communities and health researchers to effectively recruit and retain participants, particularly young survivors and advocacy organizations, while evaluating the effectiveness of pilot studies throughout the process. This funding opportunity, categorized as a discretionary federal grant, offers a total estimated program funding of $24 million, with individual awards ranging from $0 to $1 million, and is expected to support approximately six projects. Interested applicants can reach out to Eduardo O'Neill, PhD, at 404-718-8844 or via email at fzt4@cdc.gov for further information, with applications due by 5:00 PM local time on February 12, 2026.
    National Center for Construction Safety and Health Research and Translation (U54)
    Centers for Disease Control and Prevention - ERA
    The Centers for Disease Control and Prevention (CDC) is inviting applications for the National Center for Construction Safety and Health Research and Translation (U54), aimed at reducing work-related injuries and illnesses in the construction industry. This funding opportunity encourages multidisciplinary research and intervention strategies that focus on hazard identification, the development of safety practices, and the dissemination of best practices to enhance the health and safety of U.S. construction workers. The initiative aligns with national public health goals, including the Healthy People 2030 objectives, and emphasizes collaboration with various stakeholders to address significant health burdens in the construction workforce. The total funding available is approximately $28.75 million over five years, with individual awards capped at $5.75 million per budget year. Interested applicants must submit a Letter of Intent by November 1, 2023, and complete applications by December 1, 2023, with subsequent deadlines on October 31 in the following years until 2026. For further inquiries, applicants can contact Sharon Chiou at 304-285-6029 or via email at schiou@cdc.gov.
    Long-term health outcomes of People Living with Spina Bifida based on the National Spina Bifida Patient Registry
    Centers for Disease Control - NCBDDD
    The Centers for Disease Control and Prevention (CDC) is offering a federal grant opportunity titled "Long-term health outcomes of People Living with Spina Bifida based on the National Spina Bifida Patient Registry." This initiative aims to collect high-quality longitudinal data on individuals with spina bifida through specialized clinics and to implement the Urologic Management to Preserve Initial Renal Function Protocol for young children with myelomeningocele. The funding, which ranges from $166,428 to $488,571 per award, totals approximately $2,330,000, with an expected 19 awards to be made. Interested applicants, particularly small businesses, should note that applications are due by March 16, 2026, with an estimated award date of August 11, 2026; for further inquiries, contact Stephanie Griswold at 404-718-2623 or via email at eut6@cdc.gov.
    Reducing the burden of parasitic infections in the United States through evidence-based prevention and control activities.
    Centers for Disease Control - NCEZID
    The Centers for Disease Control and Prevention (CDC) is offering a federal grant opportunity aimed at reducing the burden of parasitic infections in the United States through evidence-based prevention and control activities. This initiative seeks applications from bona fide agents representing state, territorial, local, and tribal government organizations, with the goal of implementing effective strategies to combat parasitic diseases. The total estimated program funding is $23,750,000, with individual awards ranging from $250,000 to $1,250,000, and a total of 11 awards expected to be made. Interested applicants should note that the application deadline is June 5, 2026, and they can reach out to Jamal Choice, the Project Officer, at 404.718.8228 or via email at qhi2@cdc.gov for further information.